Sales and Development Program - Capital Sales jobs in United States
cer-icon
Apply on Employer Site
company-logo

BD · 2 days ago

Sales and Development Program - Capital Sales

BD is one of the largest global medical technology companies in the world, dedicated to advancing health. The Sales and Development Program focuses on driving sales to new and existing customers while providing growth opportunities for career advancement.

Health CareMedical DeviceTechnical Support
check
Comp. & Benefits

Responsibilities

Responsible for managing, prospecting, and building relationships within an assigned territory in order to increase revenue growth and customer satisfaction. Focus areas will include driving new business as well as increasing penetration in existing accounts. Includes the sale of medical supplies and devices that have a medium length sales cycle
Responsible for the management of the sales pipeline and monthly forecasting of the business
Responsible for presenting quarterly business updates to the business units executive leadership team

Qualification

Capital sales experienceSalesforce.comMicrosoft OfficeZoom InfoProblem-solving skillsTime management skillsSelf-motivatedAttention to detail

Required

Bachelor's Degree Required
Minimum 2+ years capital sales experience in the out-of-hospital healthcare markets such EMS and Behavioral Health Centers
Ability to travel 20% of the time
Strong knowledge of Microsoft Office, Zoom Info, and Salesforce.com
Self-motivated, attention to detail, strong problem-solving and time management skills
Needs to be able to work 10am-6pm CST

Preferred

1-3 years of sales experience in Capital sales within the out-of-hospital healthcare markets such as EMS and Behavioral Health Centers

Benefits

A valuable, competitive package of compensation and benefits programs
Rewards and recognition opportunities that promote a performance-based culture

Company

BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.

Funding

Current Stage
Public Company
Total Funding
$540M
Key Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO

Leadership Team

leader-logo
Tom Polen
Chairman, CEO and President
linkedin
leader-logo
Richard Byrd
Executive Vice President and President of the BD Interventional Segment
linkedin
Company data provided by crunchbase